| Literature DB >> 29160141 |
Uylissa A Rodriguez1, Yaping Zeng2, Donald Deyo2, Margaret A Parsley2, Bridget E Hawkins1, Donald S Prough2, Douglas S DeWitt1,2.
Abstract
To determine the effects of mild blast-induced traumatic brain injury (bTBI), several groups of rats were subjected to blast injury or sham injury in a compressed air-driven shock tube. The effects of bTBI on relative cerebral perfusion (laser Doppler flowmetry [LDF]), and mean arterial blood pressure (MAP) cerebral vascular resistance were measured for 2 h post-bTBI. Dilator responses to reduced intravascular pressure were measured in isolated middle cerebral arterial (MCA) segments, ex vivo, 30 and 60 min post-bTBI. Neuronal injury was assessed (Fluoro-Jade C [FJC]) 24 and 48 h post-bTBI. Neurological outcomes (beam balance and walking tests) and working memory (Morris water maze [MWM]) were assessed 2 weeks post-bTBI. Because impact TBI (i.e., non-blast TBI) is often associated with reduced cerebral perfusion and impaired cerebrovascular function in part because of the generation of reactive oxygen and nitrogen species such as peroxynitrite (ONOO-), the effects of the administration of the ONOO- scavenger, penicillamine methyl ester (PenME), on cerebral perfusion and cerebral vascular resistance were measured for 2 h post-bTBI. Mild bTBI resulted in reduced relative cerebral perfusion and MCA dilator responses to reduced intravascular pressure, increases in cerebral vascular resistance and in the numbers of FJC-positive cells in the brain, and significantly impaired working memory. PenME administration resulted in significant reductions in cerebral vascular resistance and a trend toward increased cerebral perfusion, suggesting that ONOO- may contribute to blast-induced cerebral vascular dysfunction.Entities:
Keywords: TBI; behavior; blast-induced neurotrauma; cerebral blood flow; cerebrovascular circulation; peroxynitrite; primary blast injury; reactive oxygen species
Mesh:
Substances:
Year: 2017 PMID: 29160141 PMCID: PMC5784797 DOI: 10.1089/neu.2017.5256
Source DB: PubMed Journal: J Neurotrauma ISSN: 0897-7151 Impact factor: 5.269

(A) Shock-wave over- and underpressures (in psi) produced by the Advanced Blast Simulator (ABS) versus time. Transducer 1, driver chamber; transducers 2 and 4, specimen chamber, up- and downwind from the rat head, respectively; transducer 3, specimen chamber directly over the rat head; transducer 5, specimen chamber adjacent to the rat head. (B) Direction and orientation of the experimental animal inside the ABS. When placed in the ABS, the animal was in a transverse prone position with the dorsal surface of the head perpendicular to the shock-wave direction (arrows). Color image is available online at www.liebertpub.com/neu
Preclinical Common Data Elements for ABS bTBI
| Species | |
| Age range | 3–5 mo. prior to TBI |
| Sex | Male |
| Animal vendor | Charles River |
| Strain | Sprague-Dawley |
| Weight range | 350–480 g pre-TBI |
| Pre-TBI housing | Group housed; 12 h light/dark cycle; food and water |
| Anesthetic type | Isoflurane (4% for induction, 2% for maintenance), intubated and mechanically ventilated |
| Anesthetic route | Inhaled |
| Analgesia type | Acetaminophen suppository |
| Injury severity | Mild (blast) |
| Number of injury exposures | Single |
| Post-TBI housing | Group housed unless separated for fighting; 12 h light/dark cycle; food and water |
| Euthanasia type | 4% Isoflurane followed by decapitation |
| Acute neurological assessment | Combined neuroscore[ |
| Righting reflex response time | Mild = ≤ 7 min; moderate = 8–14 min; severe = > 14 min |
| Learning and memory tests | Morris water maze |
| Sensory/motor tests | Beam walk; beam balance |
| Anxiety and depression tests | N/A |
| Histopathology | Cellular/neuronal Injury |
| Injury model | Advanced Blast Simulator (ABS) TBI |
| Device manufacturer | ORA, Inc., Fredericksburg, VA |
| Animal stabilization method | Rat's dorsal scalp is perpendicular to the ABS blast wave with only the cranium located inside the ABS device and supported by a sling to reduce head movement. The rest of the body lies in a left lateral position outside the ABS device on a specimen tray that locks into it the blast chamber. |
| Impact location side | Central dorsal |
| Blast-induced delivery device | ABS device is a shock tube designed by David Ritzel (Dyn-FX Consulting, Ltd. Ontario, Canada) and produced by Steve Parks (ORA, Inc., Fredericksburg, VA) |
| Pressure wave type | Single pulse blast waves (Friedlander-style over- and underpressure waves) |
| Detonation type | Shockwaves produced using compressed gas driver and Mylar® membranes |
| Detonation material quantity | Mylar sheets (4) |
| Driver gas | Compressed air |
| Pressure wave medium | Air |
| Distance from detonation | 6 feet, 7 inches (2 m) |
| Blast tube or column area | 90 square inches (581 cm2) |
| Blast tube length | 14 feet (4.27 m) |
| Shock tube driven section length | 10 inches (254 mm) |
| Membrane thickness | 0.016 inches (0.4 mm/sheet) |
| Membrane burst method | Non-debris complete rupture |
| Membrane burst pressure | 179.33 psi ±3.0 (1236.4 kPA ±20.7) |
| Tube end configuration | Reflected wave suppressor |
| Distance between animal and tube | Rat's head is inside of tube |
| Animal orientation to blast wave | Perpendicular |
| Overpressure peak | 20.88 psi (138 kPa) |
| Overpressure rise time | 0.37 ms ±0.006 |
| Overpressure wave duration | 3.50 ms ±0.063 |
| Impulse | 230.34 Pa/sec ±8.9 |
| Pressure sensor type | Piezoelectric pressure probe transducers |
| Pressure sensor sampling frequency | 20 μs time sample ≥50 kHz sample rate |
| Incident Pressure Time History | <2 μs |
| Body exposure | Head only |
| Protective shielding location | N/A |
| Protective shielding type | N/A |
| Primary blast effects | Absence of external injury: occluded blood vessels, cerebral vasospasm, subarachnoid hemorrhage, tympanic membrane rupture, neuronal death/degeneration |
| Secondary blast effects | N/A |
| Tertiary blast effects | N/A |
| Quaternary blast effects | N/A |
| Systemic injuries | None |
| Extracranial injuries | None |
| Pre-bTBI surgical procedures | Isoflurane (4% initial, 2% to maintain until blast injury), intubated, mechanically ventilated, and the top of the scalp is shaved |
| Post-bTBI surgical procedures | Measurement of duration of righting reflex suppression and removal of intubation tube |
AAALAC, Association for Assessment and Accreditation of Laboratory Animal Care; USDA, United States Department of Agriculture; TBI, traumatic brain injury; bTBI, blast-induced TBI.

Effects of blast-induced traumatic brain injury (bTBI) on righting reflex (RR) suppression (n = 46/group). Mean duration of RR suppression for the bTBI group (5.19 min ±2.1) was significantly longer than in the sham group (4.27 min ±1.6). This duration of RR suppression is considered within the range of mild bTBI injury. Values are means ± SEM. *p = 0.007 versus sham.

Effects of blast-induced traumatic brain injury (bTBI) on middle cerebral arterial (MCA) responses to reduced intravascular pressure (n = 6/group). Dilator responses to progressive reductions in intravascular pressure were significantly reduced in the 30 min and 60 min bTBI groups. Values are plotted as means ± SEM. *p < 0.05 versus sham.

Effects of blast-induced traumatic brain injury (bTBI) (n = 12) or sham bTBI (n = 10) on mean arterial blood pressure (MAP), relative cerebral perfusion, and cerebral vascular resistance (CVR). (A) Although there was a trend toward elevated MAP in the bTBI group for at least 2 h after injury, the difference in MAP between the bTBI and sham group was not significant (p = 0.11, bTBI vs. sham). (B) Relative cerebral perfusion was significantly reduced in the bTBI group compared with the sham group for at least 2 h after bTBI whereas (C) CVR was significantly elevated in the bTBI group compared with the sham group for at least 2 h after bTBI. Values are plotted as means ± SEM. *p < 0.001 versus sham; **p < 0.0001 versus sham.
Effects of ABS bTBI on the Numbers of Fluoro-Jade-Positive Cells in Frontal, Parietal/Temporal, and Occipital Brain Regions
| p | ||||
|---|---|---|---|---|
| Frontal | 24 h | 74 ± 21 | 20 ± 2.3 | 0.037 |
| 48 h | 76 ± 19.5 | 23 ± 4.8 | 0.018 | |
| Parietal/temporal | 24 h | 462 ± 65.6 | 115 ± 7 | 0.003 |
| 48 h | 354 ± 31.3 | 130 ± 7.1 | 0.0005 | |
| Occipital | 24 h | 38 ± 10.6 | 11 ± 2.4 | 0.057 |
| 48 h | 28 ± 15.1 | 9 ± 2.4 | 0.320 | |
| Total | 24 h | 566 ± 20.9 | 147 ± 10.9 | 0.0004 |
| 48 h | 456 ± 17.9 | 162 ± 11.4 | 0.0001 |
bTBI, blast-induced traumatic brain injury.

Effects of blast-induced traumatic brain injury (bTBI) on cell injury in the brain (n = 6/group). (A) The number of Fluoro-Jade C (FJC) positive cells counted throughout 60 sections taken from the whole brain was significantly greater 24 and 48 h after bTBI compared with both the 24 and 48 h sham groups. (B) The numbers of FJC positive cells in the frontal (F) and parietal/temporal lobe (PT) region were significantly greater than in the sham group's F region and PT region. However, the bTBI group's occipital (O) region was not significantly different from the sham group's O region (p = 0.057, bTBI O vs. sham O). (C) The numbers of FJC positive cells in the frontal (F) and parietal/temporal lobe (PT) region were significantly greater 48 h post-bTBI in the bTBI group than in the sham group, but were not significantly different from sham in the occipital (O) region (p = 0.320, bTBI O vs. sham O). Values are plotted as means ± SEM. *p < 0.05 versus sham and F; **p < 0.001 versus sham.

Effects of blast-induced traumatic brain injury (bTBI) on beam walk, beam balance, and working memory performance (n = 10/group). (A) Beam walk performance did not differ significantly between the bTBI and sham groups (p = 0.2, bTBI vs. sham). (B) Beam balance performance did not differ significantly between the bTBI and sham groups (p = 0.06, bTBI vs. Sham). (C) bTBI and sham group times to locate the goal platform on post-injury days 11–14. (D) bTBI and sham group latencies combined across all post-injury days. Neither the individual day nor the combined latencies differed significantly between the bTBI and sham groups (p = 0.067, bTBI vs. sham). (E) Differences in latencies to the goal platform between the first and second trials for each pair of trials in the bTBI and sham groups (n = 10/group). One way analysis of variance (ANOVA) indicated that the differences in latencies combined across all 5 days were significantly longer in the sham group than in the bTBI group, suggesting that bTBI resulted in significantly impaired working memory. Values are plotted as means ± SEM. *p < 0.01 versus sham.
Effects of ABS bTBI on Vestibulomotor and Cognitive Functions
| p | |||
|---|---|---|---|
| Beam walk (bTBI vs. sham) | 0.2 | ||
| Beam balance (bTBI vs. sham) | 0.06 | ||
| Days 11–14 after bTBI (bTBI vs. sham) | 0.239 m/sec ±0.003 | 0.32 | |
| Days 11–14 after Sham | 0.219 m/sec ±0.004 | ||
| Days 11–14 after bTBI (bTBI vs. sham) | 38.2 sec ±3.4 | 0.067 | |
| Days 11–14 after sham | 30.2 sec ±3.2 | ||
| Inter-trial latency differences (bTBI vs. sham) | 0.01 |
ABS, Advanced Blast Simulator; bTBI, blast-induced traumatic brain injury; MWM, Morris water maze.
Effects of ABS bTBI on MAP, Relative Cerebral Perfusion and CVR after PenME Administration
| p | |
|---|---|
| MAP (bTBI vs. sham) | <0.01 |
| MAP (bTBI vs. bTBI+PenME) | 0.001 |
| MAP (sham vs. bTBI+PenME) | 0.24 |
| Relative cerebral perfusion (bTBI vs. sham) | <0.0001 |
| Relative cerebral perfusion (bTBI vs. bTBI+PenME) | 0.11 |
| Relative cerebral perfusion (sham vs. bTBI+PenME) | <0.0001 |
| CVR (bTBI vs. sham) | <0.01 |
| CVR (bTBI vs. bTBI+PenME) | <0.0001 |
| CVR (sham vs. bTBI+PenME) | <0.0001 |
ABS, Advanced Blast Simulator; bTBI, blast-induced traumatic brain injury; MAP, mean arterial blood pressure; CVR, cerebral vascular resistance; PenME, penicillamine methyl ester

Effects of blast-induced traumatic brain injury (bTBI) on mean arterial blood pressure (MAP), relative cerebral perfusion, and cerebral vascular resistance (CVR) after penicillamine methyl ester (PenME) treatment (n = 8/group). (A) MAP was significantly elevated in the bTBI group compared with the sham and bTBI+PenME groups. However, there were no statistically significant differences between the sham and bTBI+PenME groups (p = 0.24, sham vs. bTBI+PenME). (B) Relative cerebral perfusion was significantly reduced in both the bTBI and bTBI+PenME groups compared with sham but did not differ significantly between the bTBI and bTBI+PenME groups (p = 0.11, bTBI vs. bTBI+PenME). (C) CVR was significantly elevated in the bTBI group compared with the sham and bTBI+PenME groups, but was significantly reduced in the bTBI+PenME group compared with both the sham and bTBI groups. Values are means ± SEM. *p < 0.01 versus sham; **p < 0.001 versus bTBI+PenME; ***p < 0.0001 versus sham; p < 0.0001 versus bTBI+PenMe; p < 0.0001 versus bTBI.

Hematoxylin and eosin staining of coronal sections at bregma ±0.3 24 h after (A) sham injury and (B) blast-induced traumatic brain injury (bTBI). No abnormalities were observed in either section. Higher magnification images of the (C) sham and (D) bTBI sections of A and B, respectively, revealed intraventricular blood near the choroid plexus in both brains, but no histological abnormalities in or around the cortex and hippocampal regions of either section. Images A and B were taken at 8 × magnification; images C and D were taken at 20× magnification. Color image is available online at www.liebertpub.com/neu